ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
RheinCell Therapeutics Achieves GMP Certification contractpharma
January 15, 2021?RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization.
Pharma Sources Insight January 2025
